Training for health staff on new vax begins

Nashik: Nashik and Jalgaon administrations on Wednesday conducted a training of vaccinators, who would be involved in administering the new ZyCov-D vaccine with the needleless injectors.

WHO consultants held demonstrations using soft balls to show the process. Over 200 health workers from the district were given the training at the Nashik district civil hospital. The health officials said that the training will continue even on Thursday. In Jalgaon district too, training was given to over 40 vaccinators for two hours.

“This is the different kind of vaccine given using a needle-free device. The training was given to the health workers about administering this vaccine,” said health officials in Nashik.

The officials said that over five lakh beneficiaries are expected to be given this needle-free vaccine altogether in Nashik and Jalgaon districts.

“The training in both the districts will be over by Thursday. We are expecting that needle-free vaccination will begin in both the districts after December 15. The state government wants to complete vaccination of all the beneficiaries at the earliest,” said health officials.

“It was an interesting training session. So far, we have been administering traditional needle-based vaccines, but this is a different kind of needle-free vaccine. We were given detailed information about the vaccine and also a demonstration,” said a healthcare worker, who attended the training.

Beneficiaries opting for ZyCoV-D have to take three doses, the second one after 28 days and the third one after 56 days.

  • Related Posts

    Commissioner FDA reviews enforcement measures

    Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices